๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
468 medicines starting with โ€œNโ€
MedicineActive substanceLicence holderStatus
Nicotinell Fruit 2 mg, medicated chewing-gum
PA25456/002/001
Nicotine Dr. Reddy's Netherlands B.V. Marketed
Nicotinell Fruit 4 mg, medicated chewing-gum
PA25456/002/002
Nicotine Dr. Reddy's Netherlands B.V. Marketed
Nicotinell Fruitfusion 2 mg medicated chewing-gum
PA25456/004/001
Nicotine Dr. Reddy's Netherlands B.V. Not marketed
Nicotinell Fruitfusion 2 mg medicated chewing-gum
PA25456/004/002
Nicotine Dr. Reddy's Netherlands B.V. Not marketed
Nicotinell Mint 1 mg compressed lozenge
PA25456/001/004
Nicotine bitartrate dihydrate Dr. Reddy's Netherlands B.V. Marketed
Nicotinell Mint 1 mg compressed lozenge
PPA1463/261/001
Nicotine bitartrate dihydrate IMED Healthcare Ltd., โ€”
Nicotinell Mint 2 mg compressed lozenge
PA25456/001/005
Nicotine bitartrate dihydrate Dr. Reddy's Netherlands B.V. Marketed
Nicotinell Rapid Relief 1 mg/spray oromucosal spray, solution
PA25456/006/001
Nicotine Dr. Reddy's Netherlands B.V. Marketed
Nicotinell Tropical Fruit 2 mg medicated chewing-gum
PA25456/005/001
Nicotine Dr. Reddy's Netherlands B.V. Not marketed
Nicotinell Tropical Fruit 4 mg medicated chewing-gum
PA25456/005/002
Nicotine Dr. Reddy's Netherlands B.V. Not marketed
Nicotinell TTS 10, 7mg/24 hours Transdermal Patch
PA25456/001/001
Nicotine Dr. Reddy's Netherlands B.V. Marketed
Nicotinell TTS 20, 14mg/24 hours Transdermal Patch
PA25456/001/002
Nicotine Dr. Reddy's Netherlands B.V. Marketed
Nicotinell TTS 30, 21mg/24 hours Transdermal Patch
PA25456/001/003
Nicotine Dr. Reddy's Netherlands B.V. Marketed
Night Nurse Capsules Paracetamol 500 mg Promethazine Hydrochloride 10 mg Dextromethorphan Hydrobromide 7.5 mg
PA0678/021/001
Dextromethorphan hydrobromide, Promethazine hydrochloride, Paracetamol Haleon Ireland Limited Marketed
Night Nurse Cold Remedy oral solution Paracetamol 1000 mg/20 ml Promethazine Hydrochloride 20 mg/20 ml Dextromethorphan Hydrobromide 15 mg/20 ml
PA0678/014/001
Paracetamol, Promethazine hydrochloride, Dextromethorphan hydrobromide Haleon Ireland Limited Marketed
Nilemdo 180 mg film-coated tablets
EU/1/20/1425/001-006
Bempedoic Acid Daiichi Sankyo Europe GmbH โ€”
Nilotinib Accord 150 mg Capsule, hard
EU/1/24/1845/005-014
Nilotinib Accord Healthcare S.L.U. โ€”
Nilotinib Accord 200 mg Capsule, hard
EU/1/24/1845/015-024
Nilotinib Accord Healthcare S.L.U. โ€”
Nilotinib Accord 50 mg Capsule, hard
EU/1/24/1845/001-004
Nilotinib Accord Healthcare S.L.U. โ€”
Nilotinib Clonmel 150 mg hard capsules
PA0126/393/002
Nilotinib hydrochloride dihydrate Clonmel Healthcare Ltd Not marketed
Nilotinib Clonmel 200 mg hard capsules
PA0126/393/003
Nilotinib hydrochloride dihydrate Clonmel Healthcare Ltd Not marketed
Nilotinib Clonmel 50 mg hard capsules
PA0126/393/001
Nilotinib hydrochloride dihydrate Clonmel Healthcare Ltd Not marketed
Nimbex 2 mg/ml solution for injection/infusion
PA1691/030/001
Cisatracurium Besilate Aspen Pharma Trading Limited Marketed
Nimenrix powder and solvent for solution for injection in pre-filled syringe
EU/1/12/767/001-007
N.meningitidis serogroup a polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup c polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup w polysaccharide conjugated to tetanus toxoid, N.meningitidis serogroup y polysaccharide conjugated to tetanus toxoid Pfizer Europe MA EEIG โ€”
Nimotop 0.02% w/v Concentrate for Solution for Infusion
PA25299/001/002
Nimodipine Laboratoire X.O Marketed
Nimotop 30 mg film-coated tablets
PA25299/001/001
Nimodipine Laboratoire X.O Marketed
Nimvastid 1.5 mg hard capsules
EU/1/09/525/1-7
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 1.5 mg orodispersible tablets
EU/1/09/525/26-31
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 3 mg hard capsules
EU/1/09/525/008-013
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 3 mg orodispersible tablets
EU/1/09/525/32-36
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 4.5 mg hard capsules
EU/1/09/525/14-19
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 4.5 mg orodispersible tablets
EU/1/09/525/37-41
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 6 mg hard capsules
EU/1/09/525/20-25
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
Nimvastid 6 mg orodispersible tablets
EU/1/09/525/42-46
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto โ€”
NINLARO 2.3 mg hard capsules
EU/1/16/1094/001
Ixazomib citrate Takeda Pharma A/S โ€”
NINLARO 3 mg hard capsules
EU/1/16/1094/002
Ixazomib citrate Takeda Pharma A/S โ€”
NINLARO 4 mg hard capsules
EU/1/16/1094/003
Ixazomib citrate Takeda Pharma A/S โ€”
Nintedanib Accord 100 mg soft capsules
EU/1/24/1803/001-006
Nintedanib esylate Accord Healthcare S.L.U. โ€”
Nintedanib Accord 150 mg soft capsules
EU/1/24/1803/007-010
Nintedanib esylate Accord Healthcare S.L.U. โ€”
Nintedanib Accordpharma 100 mg soft capsules
PA2315/272/001
Nintedanib esylate Accord Healthcare Ireland Ltd. Not marketed
Nintedanib Accordpharma 150 mg soft capsules
PA2315/272/002
Nintedanib esylate Accord Healthcare Ireland Ltd. Not marketed
Nintedanib Clonmel 100 mg soft capsules
PA0126/383/001
Nintedanib esylate Clonmel Healthcare Ltd Not marketed
Nintedanib Clonmel 150 mg soft capsules
PA0126/383/002
Nintedanib esylate Clonmel Healthcare Ltd Not marketed
Nintedanib Clonmel Healthcare 100 mg soft capsules
PA0126/398/001
Nintedanib esylate Clonmel Healthcare Ltd Marketed
Nintedanib Clonmel Healthcare 150 mg soft capsules
PA0126/398/002
Nintedanib esylate Clonmel Healthcare Ltd Marketed
Nintedanib Norton 100 mg soft capsules
PA0436/060/001
Nintedanib esylate Norton Waterford Not marketed
Nintedanib Norton 150 mg soft capsules
PA0436/060/002
Nintedanib esylate Norton Waterford Not marketed
Nintedanib Teva 100 mg soft capsules
PA22579/007/001
Nintedanib esylate TEVA GmbH Marketed
Nintedanib Teva 150 mg soft capsules
PA22579/007/002
Nintedanib esylate TEVA GmbH Marketed
Nintedanib Teva GmbH 100 mg Soft Capsules
PA22579/010/001
Nintedanib esylate TEVA GmbH Not marketed
โ† 2 3 4 5 6 7 8 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.